TCM Group, Cavendish Laboratory, University of Cambridge, United Kingdom.
ACS Chem Biol. 2011 Mar 18;6(3):208-17. doi: 10.1021/cb100420r. Epub 2011 Feb 15.
Traditionally a pursuit of large pharmaceutical companies, high-throughput screening assays are becoming increasingly common within academic and government laboratories. This shift has been instrumental in enabling projects that have not been commercially viable, such as chemical probe discovery and screening against high-risk targets. Once an assay has been prepared and validated, it must be fed with screening compounds. Crafting a successful collection of small molecules for screening poses a significant challenge. An optimized collection will minimize false positives while maximizing hit rates of compounds that are amenable to lead generation and optimization. Without due consideration of the relevant protein targets and the downstream screening assays, compound filtering and selection can fail to explore the great extent of chemical diversity and eschew valuable novelty. Herein, we discuss the different factors to be considered and methods that may be employed when assembling a structurally diverse compound collection for screening. Rational methods for selecting diverse chemical libraries are essential for their effective use in high-throughput screens.
传统上,高通量筛选检测法是大型制药公司的追求,但现在这种方法在学术和政府实验室中也越来越常见。这种转变对于开展一些原本没有商业可行性的项目起到了重要作用,比如化学探针发现和针对高风险靶点的筛选。一旦检测法被制备和验证,就必须用筛选化合物来填充。设计一个成功的小分子筛选集合面临着重大挑战。优化后的集合将最小化假阳性,同时最大限度地提高适合先导化合物生成和优化的化合物的命中率。如果没有充分考虑相关的蛋白质靶标和下游筛选检测法,化合物的过滤和选择可能无法充分探索化学多样性的广阔范围,也可能会错过有价值的新颖性。本文讨论了在为筛选组装结构多样的化合物集合时需要考虑的不同因素和可能采用的方法。选择多样化化学文库的合理方法对于其在高通量筛选中的有效使用至关重要。